JF
Therapeutic Areas
Xenetic Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Systemic DNase I | Pancreatic Carcinoma | Preclinical |
Leadership Team at Xenetic Biosciences
SN
Scott N. Cullison
Executive Consultant, Business Development
RP
Reid P. Bissonnette, Ph.D.
Executive Consultant, Translational Research and Development
GG
Grigory G. Borisenko, Ph.D.
Non-Executive Director
FJ
Firdaus Jal Dastoor, FCS
Non-Executive Director
DG
Dmitry Genkin, M.D.
Non-Executive Director
RK
Roger Kornberg, Ph.D.
Non-Executive Director
JS
Jonathan Spicer, M.D., Ph.D.
Scientific Advisory Board Member
AT
Allan Tsung, M.D.
Scientific Advisory Board Member